COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT03444714
Previous Study | Return to List | Next Study

Phase I Study of RiMO-301 With Radiation in Advanced Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03444714
Recruitment Status : Recruiting
First Posted : February 23, 2018
Last Update Posted : July 8, 2019
University of Chicago
Information provided by (Responsible Party):
Rimo Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2021